Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus ErythematosusInterventions: Drug: extended release dipyridamole 200mg/aspirin 25mg; Drug: 81mg aspirinSponsors: Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Oklahoma Rheumatic Disease Research Cores CenterRecruiting - verified October 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials